Oleoylethanolamide ameliorates motor dysfunction through PPARα ‐mediates oligodendrocyte differentiation and white matter integrity after ischemic stroke
Phytotherapy Research · 2023
DOI: 10.1002/ptr.7970 ↗At a glance
Journal article in Phytotherapy Research, 2023. Written by Rengong Zhuo and 16 co-authors. Institution: The Fifth Hospital of Xiamen & Institute of Cardiovascular Diseases, Xiamen Cardiovascular Hospital of Xiamen University, School of Medicine, Xiamen …. Major MEDLINE topics: White Matter, Ischemic Stroke, Brain Ischemia, Stroke. Cited 5 times so far (Crossref); 40 references. Funded by: National Natural Science Foundation of China.
Topics: Schlaganfall
Abstract (original language)
Background and Aim Our previous study has revealed that OEA promotes motor function recovery in the chronic stage of ischemic stroke. However, the neuroprotective mechanism of OEA on motor function recovery after stroke still is unexplored. Therefore, the aim of this study was to explore the effects of OEA treatment on angiogenesis, neurogenesis, and white matter repair in the peri‐infarct region after cerebral ischemia. Experimental Procedure The adult male rats were subjected to 2 h of middle cerebral artery occlusion. The rats were treated with 10 and 30 mg/kg OEA or vehicle daily starting from day 2 after ischemia induction until they were sacrificed. Key Results and Conclusions The results revealed that OEA increased cortical angiogenesis, neural progenitor cells (NPCs) proliferation, migration, and differentiation. OEA treatment enhanced the survival of newborn neurons and oligodendrogenesis, which eventually repaired the cortical neuronal injury and improved motor function after ischemic stroke. Meanwhile, OEA treatment promoted the differentiation of oligodendrocyte progenitor cells (OPCs) and oligodendrogenesis by activating the PPARα signaling pathway. Our results showed that OEA restores motor function by facilitating cortical angiogenesis, neurogenesis, and white matter repair in rats after ischemic stroke. Therefore, we demonstrate that OEA facilitates functional recovery after ischemic stroke and propose the hypothesis that the long‐term application of OEA mitigates the disability after stroke.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- The Fifth Hospital of Xiamen & Institute of Cardiovascular Diseases, Xiamen Cardiovascular Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, China.
- Institute of Materia Medica, Xinjiang University, Urumqi, China.
- Department of Pharmacy, The First Hospital of Hebei Medical University, Shijiazhuang, China.
- Xiang'an Hospital of Xiamen University, Xiamen, China.
- Xiamen Medical College, Xiamen, China.
- The Huadong Hospital Affiliated to Fudan University, Shanghai, China.
ORCID profiles: Lichao Yang
Funding
- National Natural Science Foundation of China
Cite
APA
Zhuo, R., Song, Z., Wang, Y., Zhu, M., Liu, F., Lin, P., Rao, R., Zhou, Y., Zhao, Y., Fan, Z., Cui, L., Liu, H., Li, J., Li, Y., Guo, H., Cai, C. F., & Yang, L. (2023). Oleoylethanolamide ameliorates motor dysfunction through PPARα ‐mediates oligodendrocyte differentiation and white matter integrity after ischemic stroke. Phytotherapy Research. https://doi.org/10.1002/ptr.7970
Vancouver
Zhuo R, Song Z, Wang Y, Zhu M, Liu F, Lin P, et al. Oleoylethanolamide ameliorates motor dysfunction through PPARα ‐mediates oligodendrocyte differentiation and white matter integrity after ischemic stroke. Phytotherapy Research. 2023. doi:10.1002/ptr.7970
BibTeX
@article{Zhuo2023,
author = {Zhuo, Rengong and Song, Zhengmao and Wang, Yun and Zhu, Maoshu and Liu, Feng and Lin, Pingli and Rao, Rong and Zhou, Yu and Zhao, Yun and Fan, Zhongxiong and Cui, Lishan and Liu, Hongtao and Li, Jingwen and Li, Ying and Guo, Han and Cai, Cheng Fu and Yang, Lichao},
title = {Oleoylethanolamide ameliorates motor dysfunction through PPARα ‐mediates oligodendrocyte differentiation and white matter integrity after ischemic stroke},
journal = {Phytotherapy Research},
year = {2023},
doi = {10.1002/ptr.7970}
}
EUVIMED